ACOU085 for Hearing Loss Prevention in Testicular Cancer Patients Receiving Cisplatin — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(10 sites)
Germany
Dept. of Otolaryngology - Head and Neck Surgery, Tuebingen University, Tübingen, Baden-Wurttemberg Dept. of Otolaryngology - Head and Neck Surgery, Dresden University, Dresden Dept. of Otolaryngology - Head and Neck Surgery, Essen University, Essen Department of Otolaryngology - Head and Neck Surgery, Hamburg University, Hamburg Dept. of Otolaryngology - Head and Neck Surgery, Jena University, Jena Dept. of Otolaryngology - Head and Neck Surgery, Mannheim University, Mannheim Dept. of Otolaryngology - Head and Neck Surgery, Marburg University, Marburg Dept. of Hematology and Oncology, Rotkreuzklinikum Munich, Munich Dept. of Otolaryngology - Head and Neck Surgery, Munich Technical University, Munich Dept. of Otolaryngology - Head and Neck Surgery, Wuerzburg University, Würzburg Last updated September 2024